Adults with a reduced ability to perform daily activities due to Long COVID by gender U.S. 2022-2023

According to a survey conducted in the U.S. as of July 10, 2023, the share of adults reporting activity limitations from Long COVID was higher among females than males. As of that date, roughly 82.5 percent of female respondents experiencing Long COVID suffered from activity limitations due to this condition, while 76.6 percent of males reported the same. This statistic shows the percentage of adults who reported any activity limitations from Long COVID in the U.S. from September 14, 2022 to July 10, 2023, by gender.

Percentage of adults in the United States with Long COVID who reported any activity limitations from the condition from September 14, 2022 to July 10, 2023, by gender

Characteristic	Female	Male
September 14 to 26, 2022	80.4%	83%
October 5 to 17, 2022	80.1%	79.7%
November 2 to 14, 2022	78.2%	79.1%
December 9 to 19, 2022	78.8%	83.9%
January 4 to 16, 2023	78.9%	78.7%
February 1 to 13, 2023	78.9%	81.3%
March 1 to 13, 2023	78.8%	84.2%
March 29 to April 10, 2023	80.6%	81.6%
April 26 to May 8, 2023	79.2%	78.8%
June 7 to June 19, 2023	80.2%	83.3%
June 28 to July 10, 2023	82.5%	76.6%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

July 2023

More information

Region

United States

Survey time period

September 14, 2022 to July 10, 2023

Age group

18 years and older

Special properties

estimates; among adults who currently have Long COVID

Method of interview

Online survey

Supplementary notes

The Household Pulse Survey is an online survey released in different phases:

Phase 3.6
September 14 to 26, 2022. Sample size: 50,258
October 5 to 17, 2022. Sample size: 41,415
November 2 to14, 2022. Sample size: 60,626

Phase 3.7
December 9 to 19, 2022. Sample size: 69,373
January 4 to 16, 2023. Sample size: 67,279
February 1 to 13, 2023. Sample size: 74,314

Phase 3.8
March 1 to 13, 2023. Sample size: 71,278
March 29 to April 10, 2023. Sample size: 60,738
April 26 to May 8, 2023. Sample size: 58,188

Phase 3.9
June 7 to 19, 2023. Sample size: 63,429
June 28 to July 10, 2023. Sample size: 62,478

The question was phrased as follows: "Do these long-term symptoms reduce your ability to carry out day-to-day activities compared with the time before you had COVID-19?"